Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 53 (Search time: 0.007 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Pathobiology of cancer regimen-related toxicitiesDowney, G.; Sonis, S.; Keefe, D.
2014Baseline patient characteristics, incidence of CINV, and physician perception of CINV incidence following moderately and highly emetogenic chemotherapy in Asia Pacific countriesHsieh, R.; Chan, A.; Kim, H.; Yu, S.; Kim, J.; Lee, M.; Dalén, J.; Jung, H.; Liu, Y.; Burke, T.; Keefe, D.
2010Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti ratAl-Dasooqi, N.; Gibson, R.; Bowen, J.; Logan, R.; Stringer, A.; Keefe, D.
2016Enabling oral SN38-based chemotherapy with a combined lipophilic prodrug and self-microemulsifying drug delivery systemBala, V.; Rao, S.; Bateman, E.; Keefe, D.; Wang, S.; Prestidge, C.
2010Pro-inflammatory cytokines play a key role in the development of radiotherapy-induced gastrointestinal mucositisOng, Z.; Gibson, R.; Bowen, J.; Stringer, A.; Darby, J.; Logan, R.; Yeoh, A.; Keefe, D.
2015Antiemetic therapy in Asia Pacific countries for patients receiving moderately and highly emetogenic chemotherapy-a descriptive analysis of practice patterns, antiemetic quality of care, and use of antiemetic guidelinesYu, S.; Burke, T.; Chan, A.; Kim, H.; Hsieh, R.; Hu, X.; Liang, J.; Baños, A.; Spiteri, C.; Keefe, D.
2012Tumor control versus adverse events with targeted anticancer therapiesKeefe, D.; Bateman, E.
2011Patient-reported outcomes in supportive careBateman, E.; Keefe, D.
2013Predictors of acute adverse events from rapid rituximab infusionLang, S.; Keefe, D.; Schultz, T.; Pearson, A.
2017Dacomitinib-induced diarrhoea is associated with altered gastrointestinal permeability and disruption in ileal histology in ratsVan Sebille, Y.; Gibson, R.; Wardill, H.; Secombe, K.; Ball, I.; Keefe, D.; Finnie, J.; Bowen, J.